Learning Objectives:
  1. Understand Mirikizumab clinical trial data in UC.
  2. Understand Risankizumab efficacy data for Crohn's.
  3. Review head-to-head data of Risankizumab vs Ustekinumab for Crohn's.
Session date: 
02/06/2024 - 4:30pm to 5:30pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Sushila Dalal